EU authorises Novavax as fifth Covid vaccine

Novavax's jab is a protein-based vaccine of the kind used around the world to protect against many childhood illnesses

The European Commission on Monday authorised a vaccine from US company Novavax as its fifth official jab for use across the European Union, hours after the EU medicines watchdog gave approval.

- 'Promising results' - Earlier Monday, the European Medicines Agency (EMA) gave the green light for the jab to be given conditional marketing authorisation.